Verastem Stock Analysis

Verastem Stock Analysis Notes

About 60.0% of the company outstanding shares are owned by institutional investors. The company recorded a loss per share of 3.14. Verastem had not issued any dividends in recent years. The entity had 1:12 split on the 1st of June 2023. Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. The company was incorporated in 2010 and is headquartered in Needham, Massachusetts. Verastem operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 48 people. For more information please call Daniel Paterson at 781 292 4200 or visit https://www.verastem.com.

Verastem Investment Alerts

Verastem Upcoming and Recent Events

Verastem Largest EPS Surprises

View All Earnings Estimates

Verastem Environmental, Social, and Governance (ESG) Scores

Verastem Thematic Classifications

Verastem Stock Institutional Investors

Note, although Verastem's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Verastem Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 203.39 M.

Verastem Profitablity

Management Efficiency

Verastem has return on total asset (ROA) of (0.4731) % which means that it has lost $0.4731 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.3687) %, meaning that it created substantial loss on money invested by shareholders. Verastem's management efficiency ratios could be used to measure how well Verastem manages its routine affairs as well as how well it operates its assets and liabilities. As of the 29th of November 2024, Return On Tangible Assets is likely to drop to -0.61. In addition to that, Return On Capital Employed is likely to drop to -0.78. At this time, Verastem's Other Current Assets are very stable compared to the past year. As of the 29th of November 2024, Non Current Assets Total is likely to grow to about 11.4 M, while Non Currrent Assets Other are likely to drop about 4.2 M.

Technical Drivers

As of the 29th of November, Verastem has the Semi Deviation of 4.54, risk adjusted performance of 0.1544, and Coefficient Of Variation of 525.68. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Verastem, as well as the relationship between them. Please validate Verastem jensen alpha and semi variance to decide if Verastem is priced more or less accurately, providing market reflects its prevalent price of 4.57 per share. Given that Verastem has jensen alpha of 0.9878, we advise you to double-check Verastem's current market performance to make sure the company can sustain itself at a future point.

Verastem Price Movement Analysis

Verastem Insider Trading Activities

Verastem Outstanding Bonds

Verastem Predictive Daily Indicators

Verastem Corporate Filings

Verastem Forecast Models

Verastem's time-series forecasting models are one of many Verastem's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Verastem's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Verastem prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Verastem shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Verastem. By using and applying Verastem Stock analysis, traders can create a robust methodology for identifying Verastem entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Verastem analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Verastem analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Verastem stock analysis indicators help investors evaluate how Verastem stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Verastem shares will generate the highest return on investment. By understating and applying Verastem stock analysis, traders can identify Verastem position entry and exit signals to maximize returns.

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Verastem. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. To learn how to invest in Verastem Stock, please use our How to Invest in Verastem guide.You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Verastem. If investors know Verastem will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Verastem listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Verastem is measured differently than its book value, which is the value of Verastem that is recorded on the company's balance sheet. Investors also form their own opinion of Verastem's value that differs from its market value or its book value, called intrinsic value, which is Verastem's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Verastem's market value can be influenced by many factors that don't directly affect Verastem's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Verastem's value and its price as these two are different measures arrived at by different means. Investors typically determine if Verastem is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Verastem's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.